HOME >> MEDICINE >> NEWS
New treatment appears effective for rosacea

CHICAGO Application of a new formulation of azelaic acid gel to the face reduces the redness and lesions associated with rosacea better than a commonly used treatment (metronidazole gel), according to an article in the November issue of The Archives of Dermatology, one of the JAMA/Archives journals.

Rosacea is a chronic skin condition characterized by red, flaky patches on the nose and cheeks and sometimes accompanied by lesions that appear similar to small pimples. According to the article, rosacea usually fist appears in people between the ages of 30 and 60 years. Rosacea seems to respond well to topical antimicrobial treatments (creams or gels that kill microorganisms like bacteria), although the mechanisms behind this are not well understood, especially because no microorganisms have been identified as causes of rosacea. Azelaic acid and metronidazole are two antimicrobial preparations used to treat acne, and have also been observed to reduce skin conditions associated with rosacea. A new product containing 15 percent azelaic acid has been formulated specifically to treat rosacea.

Boni E. Elewski, M.D., of the University of Alabama at Birmingham, and colleagues conducted a randomized, double-blind study to compare the new 15 percent azelaic acid gel (Finacea; Berlex Laboratories, Inc., Montville, N.J.) with 0.75 percent metronidazole gel (MetroGel; Galderma Laboratories LP, Fort Worth, Tex.) in treating patients with rosacea. The researchers randomly assigned 251 patients (aged 18 years or older) to use either azelaic acid gel (n=124) or metronidazole gel (n=127). The patients applied the gels to the affected areas twice a day for 15 weeks. Participants enrolled in the study between October 29, 2001 and January 31, 2002.

The researchers found that the azelaic acid gel was better than metronidazole gel at reducing the number of lesions associated with rosacea. Fifty-six percent of patients in the azelaic acid gel group experienced
'"/>

Contact: Hank Black
205-934-3884
JAMA and Archives Journals
17-Nov-2003


Page: 1 2

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Chronic pain treatments more effective when taken together, new study shows
3. Brain activity prior to treatment flags vulnerability to antidepressant side effects
4. Cultural and social factors influence prostate cancer treatment
5. Research offers hope of new treatments for liver damage
6. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
7. Stanford patient is first to test new treatment for peripheral arterial disease
8. Scientist works on innovative treatments for brain tumors
9. Blacks less likely to get expensive, newer heart treatments
10. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
11. Study examines lessons learned at Africas first public antiretroviral treatment clinic

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2020)... ... June 02, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... Mr. Lickfold succeeds John McGill, who, following a period of transition, plans to ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... South Carolina conducting Phase I-IV trials, commemorated May, Mental Health Awareness Month, and ... medical advances possible. , Efforts include their #StayConnected video series raising awareness ...
(Date:5/30/2020)... , ... May 30, 2020 , ... ... technology and virtual solutions that can meet the needs of a COVID-riddled world, ... HashCash’s healthcare solutions abide by the necessary compliances and augment the caregiving ...
(Date:5/28/2020)... ... May 28, 2020 , ... Today the ... Shield protection. Donors can now be reimbursed for lost wages and travel/lodging costs ... six Donor Shield protections include lost wage reimbursement for donation, travel & lodging ...
(Date:5/27/2020)... N.J. (PRWEB) , ... May 27, 2020 , ... ... manufacturer, announces that it is now manufacturing face shields to be used ... coronavirus that causes COVID-19. These face shields are single use, made to be ...
Breaking Medicine News(10 mins):
(Date:6/2/2020)... MADISON, N.J. (PRWEB) , ... June 02, 2020 ... ... from political leaders and medical professionals, but confidence in those sources varies widely. ... of Pharmacy and Health Sciences finds that Americans are more likely to trust ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... in response to the U.S. announcement that it will terminate its relationship with ... announcement that it plans to terminate its relationship with the World Health Organization. ...
(Date:5/28/2020)... ... May 28, 2020 , ... Deborah ... and an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute, ... obstructive pulmonary disease (COPD). , COPD is a growing and devastating disease and ...
Breaking Medicine Technology:
Cached News: